Cited by 16

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Systematic elucidation of genetic mechanisms underlying cholesterol uptake

Hamilton, Marisa C., Fife, James D., Akinci, Ersin, Yu, Tian, Khowpinitchai, Benyapa, Cha, Minsun, Barkal, Sammy, Thi, Thi Tun, Yeo, Grace H.T., Ramos Barroso, Juan Pablo, Francoeur, Matthew Jake, Velimirovic, Minja, Gifford, David K., Lettre, Guillaume, Yu, Haojie, Cassa, Christopher A., Sherwood, Richard I.·2023·Cell Genomics

Published version of a preprint

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xgen.2023.100304

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individual cells with disrupted PCSK9 will remain sensitive to the extracellular PCSK9 secreted by neighboring cells, precluding their development of a LDLR-mediated phenotype in this study and in prior pooled CRISPR screens.

    “For example, individual cells with disrupted PCSK9 will remain sensitive to the extracellular PCSK9 secreted by neighboring cells, precluding their development of a LDLR-mediated phenotype in this study and in prior pooled CRISPR screens for LDL uptake or LDLR abundance56,80,93.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 101

  1. 2016, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1459, 10.1016/S0140-6736(16)31012-1 · DOI · Paper page
  2. Mundal, 2018, Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia, Heart, 104, 1600, 10.1136/heartjnl-2017-312706 · DOI
  3. Global Lipids Genetics Consortium, 2018, Genetics of blood lipids among ∼300,000 multi-ethnic participants of the Million Veteran Program, Nat. Genet., 50, 1514, 10.1038/s41588-018-0222-9 · DOI · Paper page
  4. Klarin, 2017, Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease, Nat. Genet., 49, 1392, 10.1038/ng.3914 · DOI
  5. Willer, 2013, Discovery and refinement of loci associated with lipid levels, Nat. Genet., 45, 1274, 10.1038/ng.2797 · DOI
  6. Howson, 2017, Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms, Nat. Genet., 49, 1113, 10.1038/ng.3874 · DOI
  7. Nikpay, 2015, A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease, Nat. Genet., 47, 1121, 10.1038/ng.3396 · DOI · Paper page
  8. Musunuru, 2019, Genetics of common, complex coronary artery disease, Cell, 177, 132, 10.1016/j.cell.2019.02.015 · DOI
  9. Jurgens, 2022, Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank, Nat. Genet., 54, 240, 10.1038/s41588-021-01011-w · DOI
  10. Wang, 2021, Rare variant contribution to human disease in 281,104 UK Biobank exomes, Nature, 597, 527, 10.1038/s41586-021-03855-y · DOI · Paper page
  11. Hindy, 2022, Rare coding variants in 35 genes associate with circulating lipid levels-A multi-ancestry analysis of 170,000 exomes, Am. J. Hum. Genet., 109, 81, 10.1016/j.ajhg.2021.11.021 · DOI
  12. Backman, 2021, Exome sequencing and analysis of 454,787 UK Biobank participants, Nature, 599, 628, 10.1038/s41586-021-04103-z · DOI
  13. Berberich, 2019, The complex molecular genetics of familial hypercholesterolaemia, Nat. Rev. Cardiol., 16, 9, 10.1038/s41569-018-0052-6 · DOI
  14. Young, 2012, Lowering plasma cholesterol by raising LDL receptors—revisited, N. Engl. J. Med., 366, 1154, 10.1056/NEJMe1202168 · DOI
  15. Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest., 109, 1125, 10.1172/JCI0215593 · DOI · Paper page
  16. Blattmann, 2013, RNAi–based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function, PLoS Genet., 9, 10.1371/journal.pgen.1003338 · DOI
  17. Kraehling, 2016, Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells, Nat. Commun., 7, 10.1038/ncomms13516 · DOI · Paper page
  18. Thormaehlen, 2015, Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and myocardial infarction, PLoS Genet., 11, 10.1371/journal.pgen.1004855 · DOI
  19. Aden, 1979, Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line, Nature, 282, 615, 10.1038/282615a0 · DOI
  20. Zhou, 2019, Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2, Nucleic Acids Res., 47, 3846, 10.1093/nar/gkz169 · DOI · Paper page
  21. Partridge, 2020, Occupancy maps of 208 chromatin-associated proteins in one human cell type, Nature, 583, 720, 10.1038/s41586-020-2023-4 · DOI · Paper page
  22. Zelcer, 2009, LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor, Science, 325, 100, 10.1126/science.1168974 · DOI · Paper page
  23. Joung, 2017, Genome-scale CRISPR-cas9 knockout and transcriptional activation screening, Nat. Protoc., 12, 828, 10.1038/nprot.2017.016 · DOI · Paper page
  24. Wang, 2019, Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute, Nat. Protoc., 14, 756, 10.1038/s41596-018-0113-7 · DOI
  25. Lambert, 2018, The human transcription factors, Cell, 172, 650, 10.1016/j.cell.2018.01.029 · DOI · Paper page
  26. Lin, 2020, Comprehensive mapping of key regulatory networks that drive oncogene expression, Cell Rep., 33, 10.1016/j.celrep.2020.108426 · DOI
  27. Lucero, 2022, Transgelin: a new gene involved in LDL endocytosis identified by a genome-wide CRISPR-Cas9 screen, J. Lipid Res., 63, 100160, 10.1016/j.jlr.2021.100160 · DOI
  28. Smith, 2021, CSDE1 is a post-transcriptional regulator of the LDL receptor, bioRxiv
  29. Ye, 2011, Regulation of cholesterol and fatty acid synthesis, Cold Spring Harb. Perspect. Biol., 3, 10.1101/cshperspect.a004754 · DOI · Paper page
  30. Yin, 2011, Hepatic HNF4α is essential for maintaining triglyceride and cholesterol homeostasis, Arterioscler. Thromb. Vasc. Biol., 31, 328, 10.1161/ATVBAHA.110.217828 · DOI
  31. Luo, 2020, Mechanisms and regulation of cholesterol homeostasis, Nat. Rev. Mol. Cell Biol., 21, 225, 10.1038/s41580-019-0190-7 · DOI · Paper page
  32. Tanenbaum, 2014, A protein-tagging system for signal amplification in gene expression and fluorescence imaging, Cell, 159, 635, 10.1016/j.cell.2014.09.039 · DOI
  33. Konermann, 2015, Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex, Nature, 517, 583, 10.1038/nature14136 · DOI · Paper page
  34. Sanson, 2018, Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities, Nat. Commun., 9, 5416, 10.1038/s41467-018-07901-8 · DOI · Paper page
  35. Kim, 2019, SpCas9 activity prediction by DeepSpCas9, a deep learning–based model with high generalization performance, Sci. Adv., 5, 10.1126/sciadv.aax9249 · DOI
  36. Doench, 2016, Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9, Nat. Biotechnol., 34, 184, 10.1038/nbt.3437 · DOI · Paper page
  37. Tsherniak, 2017, Defining a cancer dependency Map, Cell, 170, 564, 10.1016/j.cell.2017.06.010 · DOI · Paper page
  38. Boyle, 2018, High-resolution mapping of cancer cell networks using co-functional interactions, Mol. Syst. Biol., 14, 10.15252/msb.20188594 · DOI
  39. Kim, 2019, A network of human functional gene interactions from knockout fitness screens in cancer cells, Life Sci. Alliance, 2, 10.26508/lsa.201800278 · DOI
  40. Wang, 2017, Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic ras, Cell, 42, 890, 10.1016/j.cell.2017.01.013 · DOI · Paper page
  41. Amici, 2021, FIREWORKS: a bottom-up approach to integrative coessentiality network analysis, Life Sci. Alliance, 4, 10.26508/lsa.202000882 · DOI
  42. Nepusz, 2012, Detecting overlapping protein complexes in protein-protein interaction networks, Nat. Methods, 9, 471, 10.1038/nmeth.1938 · DOI
  43. Chua, 2018, Rab 10-a traffic controller in multiple cellular pathways and locations, J. Cell. Physiol., 233, 6483, 10.1002/jcp.26503 · DOI · Paper page
  44. Gulbranson, 2017, RABIF/MSS4 is a Rab-stabilizing holdase chaperone required for GLUT4 exocytosis, Proc. Natl. Acad. Sci., 114, E8224, 10.1073/pnas.1712176114 · DOI · Paper page
  45. Sano, 2011, Insulin-stimulated GLUT4 protein translocation in adipocytes requires the Rab10 guanine nucleotide exchange factor Dennd4C, J. Biol. Chem., 286, 16541, 10.1074/jbc.C111.228908 · DOI
  46. Zeng, 2017, Polarized exocytosis, Cold Spring Harb. Perspect. Biol., 9, 10.1101/cshperspect.a027870 · DOI
  47. Islam, 2022, Low-density lipoprotein internalization, degradation and receptor recycling along membrane contact sites, Front. Cell Dev. Biol., 10, 826379, 10.3389/fcell.2022.826379 · DOI
  48. Grindstaff, 1998, Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cells, Cell, 93, 731, 10.1016/S0092-8674(00)81435-X · DOI · Paper page
  49. Bermudez-Cabrera, 2021, Small molecule inhibition of ATM kinase increases CRISPR-Cas9 1-bp insertion frequency, Nat. Commun., 12, 5111, 10.1038/s41467-021-25415-8 · DOI
  50. McDermott, 2019, Large-scale compound screens and pharmacogenomic interactions in cancer, Curr. Opin. Genet. Dev., 54, 12, 10.1016/j.gde.2019.02.002 · DOI
  51. Bycroft, 2018, The UK Biobank resource with deep phenotyping and genomic data, Nature, 562, 203, 10.1038/s41586-018-0579-z · DOI · Paper page
  52. Hung, 2012, Gene set enrichment analysis: performance evaluation and usage guidelines, Brief. Bioinform., 13, 281, 10.1093/bib/bbr049 · DOI
  53. Povysil, 2019, Rare-variant collapsing analyses for complex traits: guidelines and applications, Nat. Rev. Genet., 20, 747, 10.1038/s41576-019-0177-4 · DOI
  54. Kircher, 2014, A general framework for estimating the relative pathogenicity of human genetic variants, Nat. Genet., 46, 310, 10.1038/ng.2892 · DOI · Paper page
  55. Carter, 2013, Identifying Mendelian disease genes with the variant effect scoring tool, BMC Genom., 14, S3, 10.1186/1471-2164-14-S3-S3 · DOI
  56. Pollard, 2010, Detection of nonneutral substitution rates on mammalian phylogenies, Genome Res., 20, 110, 10.1101/gr.097857.109 · DOI · Paper page
  57. Landrum, 2014, ClinVar: public archive of relationships among sequence variation and human phenotype, Nucleic Acids Res., 42, D980, 10.1093/nar/gkt1113 · DOI · Paper page
  58. Cohen, 2006, Sequence variations in PCSK9, low LDL, and protection against coronary heart disease, N. Engl. J. Med., 354, 1264, 10.1056/NEJMoa054013 · DOI · Paper page
  59. ENCODE Project Consortium, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 · DOI · Paper page
  60. McLean, 2010, GREAT improves functional interpretation of cis-regulatory regions, Nat. Biotechnol., 28, 495, 10.1038/nbt.1630 · DOI · Paper page
  61. Koornneef, 2011, Apolipoprotein B knockdown by AAV-delivered shRNA lowers plasma cholesterol in mice, Mol. Ther., 19, 731, 10.1038/mt.2011.6 · DOI
  62. Lei, 2016, Increased hepatic fatty acids uptake and oxidation by LRPPRC-driven oxidative phosphorylation reduces blood lipid levels, Front. Physiol., 7, 270, 10.3389/fphys.2016.00270 · DOI
  63. Ding, 2014, Permanent alteration of PCSK9 with in vivo CRISPR-cas9 genome editing, Circ. Res., 115, 488, 10.1161/CIRCRESAHA.115.304351 · DOI · Paper page
  64. Frank-Kamenetsky, 2008, Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates, Proc. Natl. Acad. Sci. USA, 105, 11915, 10.1073/pnas.0805434105 · DOI
  65. Welty, 2020, Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease, Curr. Opin. Lipidol., 31, 49, 10.1097/MOL.0000000000000663 · DOI
  66. Wellcome Trust Case Control Consortium, 2012, Bayesian refinement of association signals for 14 loci in 3 common diseases, Nat. Genet., 44, 1294, 10.1038/ng.2435 · DOI
  67. Moore, 2019, Arid1a loss drives nonalcoholic steatohepatitis in mice through epigenetic dysregulation of hepatic lipogenesis and fatty acid oxidation, Hepatology, 69, 1931, 10.1002/hep.30487 · DOI
  68. Ramdas, 2021, A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids, Genomics, 109, 1366
  69. Anastasia, 2021, Mitochondria-rough-ER contacts in the liver regulate systemic lipid homeostasis, Cell Rep., 34, 10.1016/j.celrep.2021.108873 · DOI
  70. MÜLLER, 1939, Angina pectoris in hereditary xanthomatosis, Arch. Intern. Med., 64, 675, 10.1001/archinte.1939.00190040016002 · DOI
  71. Wilson, 2013, Lipids and vascular disease: a framingham perspective, Glob. Heart, 8, 25, 10.1016/j.gheart.2012.12.009 · DOI
  72. Acampora, 1995, Forebrain and midbrain regions are deleted in Otx2-/- mutants due to a defective anterior neuroectoderm specification during gastrulation, Dev. Camb. Engl., 121, 3279
  73. Nada, 1993, Constitutive activation of Src family kinases in mouse embryos that lack Csk, Cell, 73, 1125, 10.1016/0092-8674(93)90642-4 · DOI
  74. Lv, 2015, Targeted disruption of Rab10 causes early embryonic lethality, Protein Cell, 6, 463, 10.1007/s13238-015-0150-8 · DOI · Paper page
  75. Li, 2016, A novel Rab10-EHBP1-EHD2 complex essential for the autophagic engulfment of lipid droplets, Sci. Adv., 2, 10.1126/sciadv.1601470 · DOI
  76. Suda, 1999, Functional equivalency between Otx2 and Otx1 in development of the rostral head, Development, 126, 743, 10.1242/dev.126.4.743 · DOI
  77. Lee, 2012, Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies, Am. J. Hum. Genet., 91, 224, 10.1016/j.ajhg.2012.06.007 · DOI
  78. Sanjana, 2014, Improved vectors and genome-wide libraries for CRISPR screening, Nat. Methods, 11, 783, 10.1038/nmeth.3047 · DOI · Paper page
  79. Jeng, 2019, Systematic Identification of Host Cell Regulators of Legionella pneumophila Pathogenesis Using a Genome-wide CRISPR Screen, Cell Host & Microbe, ISSN 1931-3128, 26, 551
  80. Li, 2014, MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens, Genome Biol., 15, 554, 10.1186/s13059-014-0554-4 · DOI · Paper page
  81. Erard, 2017, A CRISPR resource for individual, combinatorial, or Multiplexed gene knockout, Mol. Cell, 67, 348, 10.1016/j.molcel.2017.06.030 · DOI
  82. Chen, 2013, Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system, Cell, 155, 1479, 10.1016/j.cell.2013.12.001 · DOI
  83. Bushnell, 2017, BBMerge – accurate paired shotgun read merging via overlap, PLoS One, 12, 10.1371/journal.pone.0185056 · DOI
  84. Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinforma. Oxf. Engl., 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
  85. Anders, 2015, HTSeq--a Python framework to work with high-throughput sequencing data, Bioinforma. Oxf. Engl., 31, 166, 10.1093/bioinformatics/btu638 · DOI · Paper page
  86. Virtanen, 2020, SciPy 1.0: fundamental algorithms for scientific computing in Python, Nat. Methods, 17, 261, 10.1038/s41592-019-0686-2 · DOI · Paper page
  87. Ashburner, 2000, Gene Ontology: tool for the unification of biology, Nat. Genet., 25, 25, 10.1038/75556 · DOI · Paper page
  88. Mi, 2019, PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools, Nucleic Acids Res., 47, D419, 10.1093/nar/gky1038 · DOI
  89. van der Maaten, 2008, Visualizing Data using t-SNE, J. Mach. Learn. Res., 9, 2579
  90. 2022, Hail
  91. Karczewski, 2020, The mutational constraint spectrum quantified from variation in 141,456 humans, Nature, 581, 434, 10.1038/s41586-020-2308-7 · DOI · Paper page
  92. Cunningham, 2022, Ensembl 2022, Nucleic Acids Res., 50, D988, 10.1093/nar/gkab1049 · DOI · Paper page
  93. McLaren, 2016, The ensembl variant effect predictor, Genome Biol., 17, 122, 10.1186/s13059-016-0974-4 · DOI · Paper page
  94. Liu, 2020, dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs, Genome Med., 12, 103, 10.1186/s13073-020-00803-9 · DOI
  95. Pedregosa, 2011, Scikit-learn: Machine learning in Python, J. Mach. Learn. Res., 12, 2825
  96. Davidson-Pilon, 2019, lifelines: survival analysis in Python, J. Open Source Softw., 4, 1317, 10.21105/joss.01317 · DOI
  97. Szustakowski, 2021, Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank, Nat. Genet., 53, 942, 10.1038/s41588-021-00885-0 · DOI · Paper page
  98. Patel, 2020, Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and lynch syndrome with disease risk in adults according to family history, JAMA Netw. Open, 3, 10.1001/jamanetworkopen.2020.3959 · DOI
  99. Lee, 2011, The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism, Nat. Med., 17, 812, 10.1038/nm.2347 · DOI
  100. Benjamini, 1995, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. Ser. B Methodol., 57, 289, 10.1111/j.2517-6161.1995.tb02031.x · DOI · Paper page
  101. Sarkar, 1997, The Simes method for multiple hypothesis testing with positively dependent test statistics, J. Am. Stat. Assoc., 92, 1601, 10.1080/01621459.1997.10473682 · DOI

Cited by

Sorted by citations

Metadata

Authors
Hamilton, M. C., Fife, J. D., Akinci, E., Yu, T., Khowpinitchai, B., Cha, M., Barkal, S., Thi, T. T., Yeo, G. H. T., Ramos Barroso, J. P., Francoeur, M. J., Velimirovic, M., Gifford, D. K., Lettre, G., Yu, H., Cassa, C. A., & Sherwood, R. I.
Venue
Cell Genomics
Publisher
Elsevier BV
Published
2023-05
Volume
3
Issue
5
Pages
100304
ISSN
2666-979X
Cited by
16
References
21
Language
en
Funders
  • National Organization for Rare Disorders
  • Qatar Biomedical Research Institute, Hamad Bin Khalifa University
  • National University of Singapore
  • NIH (1R01HG008754, 1R21HG010391, R01HG010372)
  • American Cancer Society
  • American Heart Association

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review